AAV antgarde
HealthcareBiotech & Pharma
HQ: Naples, Italy
Investors: 2
A clinical-stage biotechnology company focused on developing innovative gene therapy platforms.
Investors (2)
| Fund | Status | Entry Date | Stage | Source |
|---|---|---|---|---|
| Cdp Venture Capital | Current | 2026-02-05 | - | Website |
| XGen Venture SGR | Current | - | - | Website |
Get these signals delivered weekly
Deals, exits, fundraises, and key hires from funds active in Italy — straight to your inbox.
Get Signals